SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-19-007632
Filing Date
2019-02-13
Accepted
2019-02-13 06:05:27
Documents
1
Group Members
ABG II-SO LTDABG INNOVATION-SO LTDABG MANAGEMENT LTD.ABG SRNE LTDALLY BRIDGE GROUP INNOVATION CAPITAL PARTNERS III, L.P.ALLY BRIDGE LB HEALTHCARE MASTER FUND LTDALLY BRIDGE LB MANAGEMENT LTDLI BINYU FAN

Document Format Files

Seq Description Document Type Size
1 SC 13G a18-30012_1sc13g.htm SC 13G 258977
  Complete submission text file 0001104659-19-007632.txt   261020
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Subject) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82540 | Film No.: 19593136
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address ABG MGMT LTD., UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG F4 00000
Business Address ABG MGMT LTD., UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG F4 00000 (852) 3121-9699
Ally Bridge Group Capital Partners II, L.P. (Filed by) CIK: 0001609313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13G